Phase II randomized trial comparing high-dose cisplatin with moderate- dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer

Abstract

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Similar works

    Full text

    thumbnail-image

    Available Versions